| Authors: |
Berkers CR; Division of Cell Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, de Jong A; Division of Cell Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, Schuurman KG; Division of Cell Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, Linnemann C; Division of Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; and., Meiring HD; Institute for Translational Vaccinology, 3721 MA Bilthoven, the Netherlands., Janssen L; Division of Cell Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, Neefjes JJ; Division of Cell Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, Schumacher TN; Division of Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; and., Rodenko B; Division of Cell Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;, Ovaa H; Division of Cell Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; h.ovaa@nki.nl. |